Cover Image

Expression of RARRES1 and AGBL2 and progression of conventional renal cell carcinoma

Approximately 15% of clinically localised conventional renal cell carcinoma (RCC) will develop metastasis within 5 years of follow-up. The aim of this study was to identify biomarkers predicting the postoperative tumour relapse.

Saved in:
Bibliographic Details
Main Authors: Peterfi, Lehel (Author) , Banyai, Daniel (Author) , Yusenko, Maria V. (Author) , Bjercke, Thea (Author) , Kovacs, Gyula (Author)
Format: Article (Journal)
Language:English
Published: 20 April 2020
In: British journal of cancer
Year: 2020, Volume: 122, Issue: 12, Pages: 1818-1824
ISSN:1532-1827
DOI:10.1038/s41416-020-0798-6
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41416-020-0798-6
Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41416-020-0798-6
Get full text
Author Notes:Lehel Peterfi, Daniel Banyai, Maria V. Yusenko, Thea Bjercke and Gyula Kovacs
Description
Summary:Approximately 15% of clinically localised conventional renal cell carcinoma (RCC) will develop metastasis within 5 years of follow-up. The aim of this study was to identify biomarkers predicting the postoperative tumour relapse.
Item Description:Gesehen am 07.09.2021
Physical Description:Online Resource
ISSN:1532-1827
DOI:10.1038/s41416-020-0798-6

Similar Items